Cochlear Limited
Cochlear Limited (CHEOY) Stock Overview
Explore Cochlear Limited’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.1B
P/E Ratio
54.92
EPS (TTM)
$1.84
ROE
0.20%
CHEOY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cochlear Limited (CHEOY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $113.76.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 54.92 and a market capitalization of 13.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Analyst Recommendations
Price Targets
Company Profile
Cochlear Limited provides implantable hearing solutions for adults and children worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Diggory William Howitt BE MBA
4,996
1 University Avenue, Sydney, NSW
2010